Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
72,400
-3,600 (-4.74%)
At close: Feb 6, 2026

Next Biomedical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
593,961331,554----
Enterprise Value
574,785316,300----
Last Close Price
72400.0041000.00----
PE Ratio
-115.95----
PS Ratio
39.8534.74----
PB Ratio
12.847.34----
P/TBV Ratio
12.937.39----
EV/Sales Ratio
38.5633.15----
Debt / Equity Ratio
0.180.240.700.566.25-0.37
Asset Turnover
0.260.220.160.080.070.09
Inventory Turnover
1.791.601.371.611.831.23
Quick Ratio
3.293.681.351.381.700.18
Current Ratio
3.643.951.571.591.820.24
Return on Equity (ROE)
-0.26%9.28%-41.64%-46.30%--
Return on Assets (ROA)
-1.49%-5.05%-10.57%-10.03%-13.55%-12.52%
Return on Capital Employed (ROCE)
-2.90%-7.60%-28.70%-27.30%-26.10%35.50%
Earnings Yield
-0.02%0.86%----
FCF Yield
-0.69%-0.50%----
Buyback Yield / Dilution
-19.72%-17.78%-1.10%-28.34%-13.05%-199.99%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.